| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |